Colossal Biosciences

Hill Chart Shape

Colossal Biosciences Valuation and Overview

Colossal Biosciences
Sectors
BioTech, Environmental, Entertainment
Headquarters
Dallas, TX, USA
CEO
Ben Lamm
Colossal Biosciences shares returned +315.8%, with $35.0M in secondary bids, offers, and transactions activity over the last 90 days, according to PM Insights' institutional secondary market data.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
Low
XXXXX

Business Partnerships

Targeted Impact

Who Will Benefit?

What Comes Next?

Colossal Biosciences Growth Timeline

No items found.

Colossal Biosciences and Competition

For additional insights and information on Colossal Biosciences, contact us today to access the full ApeVue report.
Request the full report

Colossal Biosciences Market Inteligence Snapshot

Colossal Biosciences Annual Revenue & Year-Over-Year Growth Rate

Colossal Biosciences Secondary Market ROI (Return on Investment)

Colossal Biosciences shares returned +315.8%, with $35.0M in secondary bids, offers, and transactions activity over the last 90 days, according to PM Insights' institutional secondary market data.

Colossal Biosciences Bid-Ask Volume Ratios (Private Secondary Market)

Colossal Biosciences Mutual Fund Valuations (NAV)

Colossal Biosciences Funding Rounds & Cap Table Details

Register today to view the full report, with more in-depth details and analytics:
Access the full report

Colossal Biosciences VC / Strategic Investors

Colossal Biosciences Research

No items found.

Colossal Biosciences News

No items found.
Register today to view the full Colossal Biosciences report, with more in-depth details and analytics:
Access the full Colossal Biosciences report

Ready to see it in action?

Schedule a demo with one of our experts